In conclusion, the results demonstrated that AT-I was an effective anti-proliferative agent towards human colorectal adenocarcinoma in vitro through the activation of caspases and pro-apoptotic Bcl-2 family proteins, and that the mitochondrial-dependent pathway is involved. This evidence concerns the gene BCL2 and colorectal adenocarcinoma.